Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atomized Intranasal Midazolam for Anxiolysis and Facilitation of Laceration Repair in the Pediatric Emergency Department: A Randomized Controlled Trial

NCT02618772 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT02618772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02618772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atomized Intranasal Midazolam for Anxiolysis and Facilitation of Laceration Repair in the Pediatric Emergency Department: A Randomized Controlled Trial
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2010
Completion date
November 30, 2015
Enrollment
79 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, lacerations